IDEXX Laboratories, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2016 | — | $-73.9M | $133.0M |
| Jun 2016 | — | $-8.6M | $141.1M |
| Sep 2016 | — | $54.9M | $150.1M |
| Dec 2016 | $593.7M | $-108.4M | $154.9M |
| Mar 2017 | — | $-74.1M | $160.4M |
| Jun 2017 | — | $-86.3M | $166.0M |
| Sep 2017 | — | $-48.6M | $169.0M |
| Dec 2017 | $606.6M | $-54.1M | $187.7M |
| Jan 2018 | — | $-58.8M | — |
| Mar 2018 | — | $-49.3M | $159.2M |
| Jun 2018 | — | $-41.1M | $174.6M |
| Sep 2018 | — | $-1.6M | $146.9M |
| Dec 2018 | $601.8M | $-9.5M | $123.8M |
| Mar 2019 | — | $51.6M | $116.6M |
| Jun 2019 | — | $171.2M | $110.8M |
| Sep 2019 | — | $202.4M | $104.0M |
| Dec 2019 | $698.9M | $177.5M | $90.3M |
| Mar 2020 | — | $107.7M | $81.4M |
| Jun 2020 | — | $273.0M | $105.3M |
| Sep 2020 | $853.3M | $440.6M | $175.6M |
| Dec 2020 | $858.5M | $632.1M | $383.9M |
| Mar 2021 | $778.7M | $702.7M | $351.2M |
| Jun 2021 | $780.1M | $747.5M | $232.1M |
| Sep 2021 | $778.0M | $754.8M | $145.2M |
| Dec 2021 | $775.2M | $690.0M | $144.5M |
| Mar 2022 | $773.4M | $639.8M | $204.6M |
| Jun 2022 | $768.0M | $457.0M | $114.4M |
| Sep 2022 | $760.8M | $476.0M | $99.2M |
| Dec 2022 | $694.4M | $608.7M | $112.5M |
| Mar 2023 | $696.4M | $841.1M | $111.4M |
| Jun 2023 | $696.8M | $1.09B | $132.8M |
| Sep 2023 | $618.8M | $1.30B | $331.7M |
| Dec 2023 | $622.9M | $1.48B | $453.9M |
| Mar 2024 | $620.8M | $1.57B | $397.4M |
| Jun 2024 | $524.7M | $1.58B | $401.6M |
| Sep 2024 | $524.8M | $1.62B | $308.6M |
| Dec 2024 | $449.8M | $1.60B | $288.3M |
| Mar 2025 | $449.8M | $1.45B | $164.0M |
| Jun 2025 | $449.8M | $1.46B | $164.6M |
| Sep 2025 | $374.8M | $1.56B | $208.2M |
| Dec 2025 | $374.8M | $1.61B | $180.1M |